BG62052B1 - [(бензодиоксан, бензофуран или бензопиран)-алкиламино]алкилзаместени гуанидини като селективни съдосвиващи средства - Google Patents

[(бензодиоксан, бензофуран или бензопиран)-алкиламино]алкилзаместени гуанидини като селективни съдосвиващи средства Download PDF

Info

Publication number
BG62052B1
BG62052B1 BG98870A BG9887094A BG62052B1 BG 62052 B1 BG62052 B1 BG 62052B1 BG 98870 A BG98870 A BG 98870A BG 9887094 A BG9887094 A BG 9887094A BG 62052 B1 BG62052 B1 BG 62052B1
Authority
BG
Bulgaria
Prior art keywords
formula
alkyl
hydrogen
amino
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
BG98870A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98870A (bg
Inventor
Guy R. Van Lommen
Marcel F. De Bruyn
Walter J. Janssens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of BG98870A publication Critical patent/BG98870A/bg
Publication of BG62052B1 publication Critical patent/BG62052B1/bg
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG98870A 1992-02-27 1994-06-24 [(бензодиоксан, бензофуран или бензопиран)-алкиламино]алкилзаместени гуанидини като селективни съдосвиващи средства Expired - Lifetime BG62052B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84256092A 1992-02-27 1992-02-27
PCT/EP1993/000435 WO1993017017A1 (fr) 1992-02-27 1993-02-19 Guanidines substituees par [(benzodioxanne, benzofuranne ou benzopyranne)-alkylamino]alkyle, utiles comme vasoconstricteurs selectifs

Publications (2)

Publication Number Publication Date
BG98870A BG98870A (bg) 1995-03-31
BG62052B1 true BG62052B1 (bg) 1999-01-29

Family

ID=25287639

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98870A Expired - Lifetime BG62052B1 (bg) 1992-02-27 1994-06-24 [(бензодиоксан, бензофуран или бензопиран)-алкиламино]алкилзаместени гуанидини като селективни съдосвиващи средства

Country Status (37)

Country Link
US (4) US5541180A (fr)
EP (1) EP0639192B1 (fr)
JP (1) JP2779268B2 (fr)
KR (1) KR100190300B1 (fr)
CN (1) CN1038032C (fr)
AP (1) AP416A (fr)
AT (1) ATE138064T1 (fr)
AU (1) AU664237B2 (fr)
BG (1) BG62052B1 (fr)
CA (1) CA2117483C (fr)
CZ (1) CZ282092B6 (fr)
DE (1) DE69302687T2 (fr)
DK (1) DK0639192T3 (fr)
EE (1) EE03029B1 (fr)
ES (1) ES2087721T3 (fr)
FI (1) FI109122B (fr)
GR (1) GR3019927T3 (fr)
HR (1) HRP930235B1 (fr)
HU (2) HU222495B1 (fr)
IL (1) IL104868A (fr)
LT (1) LT3049B (fr)
LV (1) LV10715B (fr)
MX (1) MX9301053A (fr)
MY (1) MY110627A (fr)
NO (1) NO306255B1 (fr)
NZ (1) NZ249124A (fr)
OA (1) OA10095A (fr)
PH (1) PH31295A (fr)
PL (1) PL174736B1 (fr)
RO (1) RO115630B1 (fr)
RU (1) RU2121999C1 (fr)
SG (1) SG47763A1 (fr)
SI (1) SI9300097B (fr)
SK (1) SK280166B6 (fr)
TW (1) TW225531B (fr)
WO (1) WO1993017017A1 (fr)
ZA (1) ZA931404B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824682A (en) * 1993-08-18 1998-10-20 Janssen Pharmaceutica, N.V. Vasoconstrictive dihydrobenzopyran derivatives
RU2135501C1 (ru) * 1993-08-19 1999-08-27 Жансен Фармасетика Н.В. Замещенные дигидропиранопиридины, способ их получения, промежуточные соединения, фармацевтическая композиция и способ ее получения
PH31437A (en) * 1993-08-27 1998-11-03 Janssen Pharmaceutica Nv Tontophoretic delivery of an antimigrane drug.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
HRP950149A2 (en) * 1994-04-13 1997-06-30 Janssen Pharmaceutica Nv Intranasal antimigrene composition
US6054462A (en) * 1994-04-13 2000-04-25 Janssen Pharmaceutica, N.V. Intranasal antimigraine compositions
FR2724383B1 (fr) * 1994-09-13 1996-10-18 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
EP1123933A1 (fr) * 1994-10-14 2001-08-16 MERCK PATENT GmbH 2-[5-(4-fluorophényl)-3-pyridylméthylaminométhyl]chromane agissant sur le système nerveux central
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
KR19990021931A (ko) * 1995-06-08 1999-03-25 디르크 반테 미세구형 전분의 항편두통 조성물
FR2752735B1 (fr) * 1996-09-05 1998-10-02 Synthelabo Utilisation de derives de benzofurane pour obtenir un medicament destine au traitement de l'insuffisance veineuse et de l'ulcere veineux
TW504510B (en) * 1996-05-10 2002-10-01 Janssen Pharmaceutica Nv 2,4-diaminopyrimidine derivatives
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
UA73123C2 (en) 1999-06-02 2005-06-15 Janssen Pharmaceutica Nv Derivatives of benzodioxane, benzofuran or benzopyran substituted by pyrolidinyl, piperidinyl or homopiperidinyl
CZ20014177A3 (cs) 1999-06-02 2002-05-15 Janssen Pharmaceutica N. V. Aminoalkyl substituované (benzodioxanové, benzofuranové nebo benzopyranové) deriváty
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
WO2002044159A2 (fr) * 2000-11-29 2002-06-06 Eli Lilly And Company 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl) piperazine, ses sels acceptables sur le plan pharmaceutique et ses solvants
DE60210944T3 (de) * 2001-02-23 2015-07-23 Merck Sharp & Dohme Corp. N-substituierte nichtaryl-heterocyclische nmda/nr2b antagonisten
SI1408964T1 (sl) 2001-07-26 2007-06-30 Merck Patent Gmbh Uporaba 2- 5-(4-fluorofenil)-3-piridilmetil-aminometil -kromana in njegovih fizioloĺ ko sprejemljivih soli
SI1427724T1 (sl) * 2001-09-19 2006-10-31 Merck Patent Gmbh Nova uporaba substituiranih aminometil-kromanov
CA2513055A1 (fr) * 2003-01-31 2004-08-19 Zimmer Orthobiologics, Inc. Compositions de matrices hydrogel composites et procedes pour la reparation ou le traitement de tissus mammaliens
CN100451004C (zh) * 2003-03-31 2009-01-14 大正制药株式会社 嘧啶衍生物
US20050197350A1 (en) * 2003-03-31 2005-09-08 Taisho Pharmaceutical Co., Ltd. Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
ES2533652T3 (es) * 2006-01-18 2015-04-13 Evolva Sa Moduladores de PPAR
CN105061392B (zh) * 2015-07-20 2017-07-18 上海现代哈森(商丘)药业有限公司 一种硫酸胍生合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1366479A (fr) * 1962-08-20 1964-07-10 Res Lab Dr C Janssen Nv Procédé de production de nouveaux dérivés de la pipéridine et de leurs sels
NL296841A (fr) * 1962-08-20
GB1411531A (en) * 1972-10-24 1975-10-29 Lafon Labor Amino derivatives of 1,4-benzodioxan
GR71865B (fr) * 1978-03-20 1983-07-07 Ciba Geigy
US4405922A (en) * 1979-05-23 1983-09-20 Hitachi Koki Company, Limited Failure detection circuit for impact printers or the like
US4405622A (en) * 1980-10-16 1983-09-20 Syntex (U.S.A.) Inc. [1-(1,4-Benzodioxan-2-yl)-4-(4-aminopyrimidin-2-yl]piperazines useful as anti-depressants
FR2524887A1 (fr) * 1982-04-08 1983-10-14 Bouchara Emile Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
CA1338012C (fr) * 1987-04-27 1996-01-30 John Michael Mccall Amines possedant des proprietes pharmaceutiques
CA2011899A1 (fr) * 1989-03-13 1990-09-13 Masaaki Toda Derives de benzopyran
WO1994017017A1 (fr) * 1991-07-15 1994-08-04 Exxon Research And Engineering Company Elimination du benzene des courants a limites d'ebullition de l'essence
DE4303657A1 (de) * 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate

Also Published As

Publication number Publication date
JPH07504408A (ja) 1995-05-18
AU3499193A (en) 1993-09-13
GR3019927T3 (en) 1996-08-31
SK102994A3 (en) 1995-07-11
HU9402464D0 (en) 1994-10-28
ZA931404B (en) 1994-08-26
IL104868A0 (en) 1993-06-10
BG98870A (bg) 1995-03-31
US5688952A (en) 1997-11-18
FI943928A (fi) 1994-08-26
DE69302687D1 (de) 1996-06-20
HRP930235A2 (en) 1997-10-31
EE03029B1 (et) 1997-08-15
LV10715B (en) 1995-12-20
AU664237B2 (en) 1995-11-09
SI9300097B (en) 2001-12-31
MY110627A (en) 1998-09-30
CA2117483A1 (fr) 1993-09-02
EP0639192A1 (fr) 1995-02-22
HU211742A9 (en) 1995-12-28
JP2779268B2 (ja) 1998-07-23
CN1038032C (zh) 1998-04-15
US5624952A (en) 1997-04-29
PH31295A (en) 1998-07-06
SI9300097A (en) 1993-09-30
WO1993017017A1 (fr) 1993-09-02
TW225531B (fr) 1994-06-21
LV10715A (lv) 1995-06-20
RU94041210A (ru) 1996-07-10
HU222495B1 (hu) 2003-07-28
AP9300493A0 (en) 1993-04-30
RU2121999C1 (ru) 1998-11-20
OA10095A (en) 1996-12-18
FI109122B (fi) 2002-05-31
IL104868A (en) 1998-01-04
US5541180A (en) 1996-07-30
DE69302687T2 (de) 1996-11-14
NZ249124A (en) 1995-08-28
NO306255B1 (no) 1999-10-11
FI943928A0 (fi) 1994-08-26
CS202094A3 (en) 1995-01-18
ES2087721T3 (es) 1996-07-16
EP0639192B1 (fr) 1996-05-15
AP416A (en) 1995-09-29
MX9301053A (es) 1994-03-31
HUT71129A (en) 1995-11-28
SK280166B6 (sk) 1999-09-10
US5607949A (en) 1997-03-04
CZ282092B6 (cs) 1997-05-14
CN1079470A (zh) 1993-12-15
HRP930235B1 (en) 1999-04-30
RO115630B1 (ro) 2000-04-28
LT3049B (en) 1994-10-25
KR100190300B1 (ko) 1999-06-01
LTIP367A (lt) 1994-04-25
DK0639192T3 (da) 1996-08-19
SG47763A1 (en) 1998-04-17
CA2117483C (fr) 2001-01-09
NO943186L (no) 1994-08-29
ATE138064T1 (de) 1996-06-15
PL174736B1 (pl) 1998-09-30
NO943186D0 (no) 1994-08-29

Similar Documents

Publication Publication Date Title
BG62052B1 (bg) [(бензодиоксан, бензофуран или бензопиран)-алкиламино]алкилзаместени гуанидини като селективни съдосвиващи средства
US5801179A (en) Vasoconstrictive substituted aryloxyalkyl diamines
EP0808316B1 (fr) 2,3-dihydro-1,4-dioxynopyridines substitues a effet vasoconstricteur
CA2168022C (fr) Derives de substitution de dihydropyranopyridines, vasoconstricteurs